NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 10 – Laser therapy and surgery<br />
Evidence Statements<br />
• Evidence supports using laser iridotomy with adjunctive pre-operative medication, as the treatment of<br />
choice for patients with acute angle closure.<br />
• Expert/consensus opinion suggests that in patients who experience acute angle closure in one eye, the<br />
fellow eye is at high risk of future closure and therefore prophylactic iridotomy can be clinically indicated.<br />
• Evidence strongly supports using medication to rapidly reduce intraocular pressure as a short-term<br />
measure pre-operatively, in patients with acute angle closure glaucoma.<br />
Patients with chronic angle closure and chronic angle closure glaucoma<br />
For patients with chronic angle closure, peripheral iridotomy is usually performed to relieve<br />
the pupillary block component and this usually halts the progression of synechial closure and<br />
progressive IOP elevation. However between three and nine percent of primary angle closure<br />
cases will progress to glaucoma within two years despite iridotomy (Nolan, Foster, Devereux et al<br />
2000). Iridotomy is described as the intervention of choice (AAO 2005a) as miotics may aggravate<br />
pupillary block due to anterior rotation of the ciliary body. There is evidence that for some patients,<br />
laser interventions need to be repeated over time, and that they become less effective on repeated<br />
administrations. When laser therapy does not successfully lower IOP, or if IOP begins to rise again,<br />
the next course of action may be a filtering procedure.<br />
Generally, only one laser iridotomy is required, as more than one iris hole has no greater effect on<br />
pupil block. Usually a single hole will remain open indefinitely. However, in patients with uveitis,<br />
the iris hole can close and may require re-opening.<br />
point of note<br />
After an iridotomy, between three and nine percent of primary angle closure cases will still progress<br />
to glaucoma within two years. A greater number of patients will progress to glaucoma in a slower<br />
manner, and retain occludable angles, or angles that re-narrow. Therefore post-iridotomy patients<br />
need to be kept under regular review.<br />
Laser iridoplasty: Following laser iridotomy, the angle may remain narrow with appositional contact<br />
between the iris and trabecular meshwork, or open a little then re-narrow. The mechanisms include<br />
large lens, ciliary block, and plateau iris amongst others. It will not work in synechial closure or most<br />
other forms of secondary angle closure. Contraction laser burns applied to large areas of peripheral<br />
iris will straighten peripherally curved iris and pull it away from the trabecular meshwork in some<br />
cases. A recent publication, which was outside the scope of this literature review, highlighted the<br />
paucity of literature concerning this therapy (Ng, Ang & Azzurro Blanco 2009).<br />
Failure of laser therapy: Surgery should be considered when the angle closes further, in spite of<br />
laser and medication treatment, and when the eye continues to demonstrate significant pressure<br />
elevation or risk of acute angle closure. Patients with enlarged lens or ciliary block component<br />
should have lens extraction performed prior to drainage surgery.<br />
point of note<br />
Expert opinion indicates that laser iridoplasty improves angle configuration in approximately half<br />
the patients with chronic angle closure. The effect of laser frequently reduces over one to two<br />
years. The treating health care provider must avoid over-treatment, as there is a risk of inducing iris<br />
atrophy and permanent mydriasis.<br />
National Health and Medical Research Council 145